Skip to main content
OpenTrials
Completed

NCT Number: NCT03116763

The iPeer2Peer Program for Adolescents With Juvenile Idiopathic Arthritis

The iPeer2Peer program matches teens with arthritis to an older mentor who has learned to manage their arthritis well and can support them emotionally and socially. This study will compare two groups of teens: those who are in the iPeer2Peer Program and those in the control group (no mentor).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Juvenile Idiopathic Arthritis Arthritis Arthritis, Juvenile Autoimmune Diseases Connective Tissue Diseases Immune System Diseases Joint Diseases Musculoskeletal Diseases Rheumatic Diseases Skin and Connective Tissue Diseases

Age range

12 year–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Alberta Children's Hospital, Calgary, Alberta, Canada

Loading trial locations.

About this study

Arthritis is a common childhood illness that makes everyday activities hard for young people. It is a long-lasting illness that can make you feel pain, tired and emotionally upset. This can make it hard for children and teens to see friends and do the activities that they like. The goal of this project is to find out if the newly developed peer mentoring program called iPeer2Peer helps teens with arthritis take better care of their illness and feel more connected to other people with arthritis. The iPeer2Peer program matches teens with arthritis to an older mentor who has learned to manage their arthritis well and can support them emotionally and socially. This study will compare two groups of teens: those who are in the iPeer2Peer Program and those in the control group (no mentor).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • males and females 12-18 years old
  • rheumatologist-diagnosed JIA according to ILAR criteria
  • able to speak and read English
  • access to a computer, smartphone or tablet capable of using free Skype software (note: participants who do not have adequate Internet access will be provided with portable Internet sticks)
  • willing and able to complete online measures.

Exclusion criteria

  • significant cognitive impairments
  • major co-morbid illnesses (medical or psychiatric conditions) likely to influence HRQL assessment
  • participating in other peer support or self-management interventions.

Treatment and study plan

iPeer2Peer Mentorship

Behavioral

10 sessions of 20-30 minute Skype calls conducted over 5-12 weeks.

Active Comparator: Control group

Other

The control group will receive standard care but without the iPeer2Peer program.

Primary outcomes

  1. TRANSITION-Q (measuring change)

    Time frame: Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post

    14-item measure of self-management skills that is both reliable (internally consistent, test-retest) and valid (face, construct and content validity)

Secondary outcomes

  1. PedsQL Arthritis Module (measuring change)

    Time frame: Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post

    Health-related quality of life

  2. PROMIS Pain Interference (measuring change)

    Time frame: Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post

    Pain

  3. Screen for Child Anxiety Related Disorders (measuring change)

    Time frame: Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post

    Emotional distress

  4. Center for Epidemiologic Studies Depression Scale Revised (measuring change)

    Time frame: Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post

    Emotional distress

  5. Medical Issues, Exercise, Pain and Social Support Questionnaire (measuring change)

    Time frame: Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post

    Disease knowledge

  6. Children's Arthritis Self-Efficacy (measuring change)

    Time frame: Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post

    Self-efficacy

  7. PROMIS Pediatric Peer Relationship Scale (measuring change)

    Time frame: Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post

    Perceived social support

  8. AQoL-6D, interview (measuring change)

    Time frame: Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post

    Cost utility analysis

  9. Health service use and costs (measuring change)

    Time frame: Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post

    Cost utility analysis

  10. Mentor Behavior Scale (measuring change)

    Time frame: Post-Intervention (approximately following 12 weeks of calls)

    Mentor quality

  11. PROMIS Adult Profile (measuring change)

    Time frame: At beginning of study and at end of study (approximately 3 years later)

    For mentors only: mentor physical and emotional symptoms

  12. PROMIS Satisfaction with Social Roles and Activities (measuring change)

    Time frame: At beginning of study and at end of study (approximately 3 years later)

    For mentors only: perceived social role satisfaction

  13. Chronic Disease Self-Efficacy Scale (measuring change)

    Time frame: At beginning of study and at end of study (approximately 3 years later)

    For mentors only: self-efficacy

  14. Mentor interaction form

    Time frame: Following completion of each mentee's calls (approximately following 12 weeks of calls)

    Record of interactions with mentees

Sponsors and collaborators

Lead sponsor

The Hospital for Sick Children

Other

Collaborators

  • Children's Hospital of Eastern Ontario
  • IWK Health Centre
  • Provincial Health Services Authority British Columbia

Registry information

Official study title

The iPeer2Peer Program for Adolescents With Juvenile Idiopathic Arthritis: A Randomized Controlled Trial

Acronym: iPeer2Peer

Important dates

Study start
2017
Primary completion
2023
Study completion
2023
First posted
Apr 17, 2017
Registry last updated
Nov 24, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.